Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality  by Zhang, Hui et al.
see commentary on page 1055
Dialysis outcomes and analysis of practice patterns
suggests the dialysis schedule affects day-of-week
mortality
Hui Zhang1,2, Douglas E. Schaubel1,2, John D. Kalbfleisch1,2, Jennifer L. Bragg-Gresham3,
Bruce M. Robinson3, Ronald L. Pisoni3, Bernard Canaud4, Michel Jadoul5, Takashi Akiba6, Akira Saito7,
Friedrich K. Port3 and Rajiv Saran1
1University of Michigan-Kidney Epidemiology and Cost Center, Ann Arbor, Michigan, USA; 2Department of Biostatistics, University of
Michigan, Ann Arbor, Michigan, USA; 3Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA; 4Lapeyronie University
Hospital, Montpellier, France; 5Cliniques Universitaires St-Luc, Universite´ Catholique de Louvain, Bruxelles, Belgium; 6Tokyo Women’s
Medical University, Tokyo, Japan and 7Division of Nephrology, Department of Medicine, Yokohama Dai-ichi Hospital, Atami, Japan
The risk of death for hemodialysis patients is thought to be
highest on the days following the longest interval without
dialysis (usually Mondays and Tuesdays); however, existing
results are inconclusive. To clarify this we analyzed Dialysis
Outcomes and Practice Patterns Study (DOPPS) data of
22,163 hemodialysis patients from the United States, Europe,
and Japan. Our study focused on the association between
dialysis schedule and day of the week of all-cause,
cardiovascular, and noncardiovascular mortality with day-of-
week coded as a time-dependent covariate. The models were
adjusted for dialysis schedule, age, country, DOPPS phase I
or II, and other demographic and clinical covariates, and
compared mortality on each day to the 7-day average.
Patients on a Monday–Wednesday–Friday (MWF) schedule
had elevated all-cause mortality on Mondays, and those on a
Tuesday–Thursday–Saturday (TTS) schedule had increased
risk of mortality on Tuesdays in all three regions. The
association between day-of-week mortality and schedule was
generally stronger for cardiovascular than noncardiovascular
mortality, and was most pronounced in the United States.
Unexpectedly, Japanese patients on a MWF schedule had a
higher risk of noncardiovascular mortality on Fridays, and
European patients on a TTS schedule experienced an
elevated cardiovascular mortality on Saturdays. Thus, future
studies are needed to evaluate the influence of practice
patterns on schedule-specific mortality and factors that could
modulate this effect.
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Hemodialysis (HD) patients usually experience relatively
high mortality rates; for example, B23% per annum in the
United States, 15% in Europe, and 9% in Japan. As the most
common treatment of advanced kidney failure, HD typically
requires patients to follow a strict treatment schedule, which
typically entails receiving dialysis on a three times a week
schedule, either Monday–Wednesday–Friday (MWF) or
Tuesday–Thursday–Saturday (TTS). During the intervals
between dialysis sessions, electrolytes, fluid, and various
uremic toxins accumulate and, as a result, contribute to an
increased risk of mortality. Therefore, the intermittent
dialysis schedule, MWF or TTS, may put patients at a higher
risk of death on certain days. In particular, patients on a
MWF schedule may have higher risk of death on Mondays,
whereas those on a TTS schedule may experience an elevated
risk on Tuesdays, since these days follow the longest intervals
without the benefit of dialysis.
Various studies have assessed the association between day-
of-week-specific mortality risk and dialysis schedule. For
example, Bleyer et al.1 found a significantly higher risk of
sudden death and cardiac-related death on Mondays for
MWF schedule patients, and on Tuesdays for TTS schedule
patients. Karnik et al.2 identified modifiable risk factors for
cardiac arrest in dialysis units, including age, diabetes, using a
catheter for vascular access, and being hospitalized within the
past 30 days. In addition, results from Karnik et al.2 revealed
that there is a higher risk of cardiac arrest on Mondays for
MWF schedule patients. Bleyer et al.3 applied a strict
definition of sudden death and investigated the association
between the timing of HD and occurrences of sudden death
among HD patients. The authors found an increased risk of
sudden death in the 12-h period after starting dialysis, and
also in the 12-h period at the end of the weekend interval
(that is, before starting HD, namely Monday and Tuesday).
For several reasons, previously published studies should
be interpreted with caution. Most prior studies were based
on relatively small sample sizes; most were confined to US
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patients, limiting their generalizability. Moreover, statistical
analyses were lacking in several respects. For example, results
were sometimes based on crude death rates without covariate
adjustment. In addition, for the most part, these analyses did
not examine interactions between weekday and patient
characteristics. For example, it is possible that mortality
elevations on given days may be accentuated for various
patient subgroups; for example, older patients, diabetics, and
patients with various comorbid conditions.
Our study uses data from the Dialysis Outcomes and
Practice Patterns Study (DOPPS), an international prospec-
tive observational study of HD treatment and patient
outcomes. The DOPPS-I (1996–2001) comprised over
17,000 patients in seven countries (France, Germany, Italy,
Japan, Spain, United Kingdom, and the United States) from
more than 300 dialysis facilities. The DOPPS-II (2002–2004)
population included over 12,000 patients in 12 countries
(DOPPS-I countries plus Australia/New Zealand, Belgium,
Canada, and Sweden) from more than 300 dialysis facilities.
The sampled facilities have at least 20–25 HD patients and
represent all geographic regions and all types of facilities in
each country. The DOPPS selects a random sample of HD
patients within each participating facility. In this study, we
carry out a comprehensive investigation of the association
between day-of-week-specific death rates and dialysis sched-
ule, in the United States, Japan, and several European
countries (Belgium, France, Germany, Italy, Spain, Sweden,
and United Kingdom). In addition to having a very large
sample size and long follow-up period, the DOPPS database
contains information on many demographic variables and
comorbid conditions. As the end point is time to death, we
used survival analysis (Cox regression) with day of the week
serving as a time-dependent covariate. Cox regression is well-
suited for this purpose as it is designed to handle a data
structure where time until death is potentially censored and
accurately tracks which patients are at risk on a particular
weekday. Thus, Cox regression appropriately accounts for
deaths and right censoring as they occur.
RESULTS
Baseline characteristics of the prevalent cross-section of
patients are presented in Table 1 by region. Compared with
US patients, European and Japanese patients were, on
average, more likely to be men, have lower body mass index,
and less likely to have diabetes and cardiovascular disease
(CVD). European patients tended to be older than US
patients, whereas Japanese patients were on average younger
than US patients. Each of these differences was statistically
significant (Po0.05). Subsequent models were constructed
from both prevalent (cross-sectional) and incident patients.
In total, 4395 deaths were reported during the study
period. Of the deaths, 2663 were among US patients, 1391
among European patients, and 341 among Japanese patients.
In addition, 1744 out of 4395 (40%) deaths were caused by
CVD. A total of 2489 out of 4395 (57%) deaths were among
patients on a MWF schedule, whereas 1906 (43%) were
among those on a TTS schedule.
The distribution of deaths by day of the week for each
dialysis schedule group is shown in Figure 1. For MWF
schedule patients, Monday had a much higher percentage of
deaths for US, European, and Japanese patients (19.7%,
19.6%, and 17.9%, respectively). For TTS schedule patients,
Tuesday had the highest percentage of deaths for US,
European, and Japanese patients (19.2%, 16.9%, and
19.1%, respectively). The distributions varied a little by
region. For MWF schedule patients, Friday appears to have
the highest risk of death in Japan, with B1/5 deaths
occurring on that day. For TTS schedule patients, Monday
Table 1 | Demographics by region
United States (N=4666) Europe (N=5623) Japan (N=3531)
Black (%) 35.8 1.5 0
Male (%) 54.2 57.8 61.8
Age (years) 61.1 (15.2) 62.1 (15.1) 59.7 (12.6)
BMI (kg/m2) 25.1 (6.1) 23.9 (4.7) 20.3 (3.1)
Diabetes 48.5 23.3 26.9
CVD 74.9 65.8 46.3
Abbreviations: BMI, body mass index; CVD, cardiovascular disease.
Values in the parentheses are the standard deviations.
This table is based on prevalent cross-sections of hemodialysis (HD) patients
participating in either Dialysis Outcomes and Practice Patterns Study (DOPPS) I or II.
CVD corresponds to any of the following comorbid conditions: cerebrovascular
disease, congestive heart failure, coronary heart disease, or other cardiovascular
diseases.
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Figure 1 |Distribution of deaths by day of the week for
patients receiving dialysis on Monday–Wednesday–Friday
(MWF) and Tuesday–Thursday–Saturday (TTS). (a) For MWF
schedule patients, Monday had a much higher percentage of
deaths for the US and European patients. (b) For TTS schedule
patients, Tuesday had the highest percentage of deaths for the US
and Japanese patients.
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appears to have a higher risk of death in the United States
(15.7%), whereas Saturday appears to have a higher risk of
death in Europe and Japan (18% for both).
For each region, Cox regression models were used to
estimate the covariate-adjusted day-of-week effect on death
hazard, with day of the week coded as a time-dependent
covariate. The model was set up so that the mortality hazard
on each day was compared with the 7-day average. Figure 2
contains three sets of covariate-adjusted hazard ratios (HRs)
for all-cause mortality by day of the week with MWF schedule
for US patients (Figure 2a), European patients (Figure 2b),
and Japanese patients (Figure 2c). Patients on a MWF dialysis
schedule from the United States experienced a significant
(Po0.0001) 41% higher risk of all-cause death on Mondays
relative to the 7-day average. European patients experienced a
significant 34% higher risk of all-cause death on Mondays
versus the 7-day average (P¼ 0.001), whereas patients from
Japan experienced a 27% higher risk of all-cause death on
Mondays (P¼ 0.154), as well as a 44% higher mortality risk
on Fridays (P¼ 0.04).
Corresponding results for TTS schedule patients are shown
in Figure 3, with each weekday again being compared with the
overall average. A significant 39% higher risk of all-cause
mortality was observed on Tuesdays for the US patients
(Po0.0001). European patients experienced a significant 22%
higher risk of all-cause death on Tuesdays (P¼ 0.043) and a
significant 31% higher risk of all-cause death on Saturdays
(P¼ 0.013). Japanese patients experienced a significant 43%
higher risk of all-cause death on Tuesdays (P¼ 0.044), as well
as a 43% higher risk on Saturdays (P¼ 0.07).
Figure 4 shows covariate-adjusted HRs of CVD and non-
CVD mortality by day of the week for MWF schedule
patients. In the United States, CVD mortality risk was higher
by 45% on Mondays relative to the 7-day average
(Po0.0001); the corresponding value for non-CVD mortality
was 38% (Po0.0001). In Europe, patients experienced a
significant 55% higher risk of CVD mortality on Mondays
(P¼ 0.006), while also experiencing a significant 27% higher
risk of non-CVD mortality on Mondays (P¼ 0.023). In
Japan, CVD mortality risk was higher by 62% on Mondays
(P¼ 0.098); the corresponding value for non-CVD mortality
was 10% (P¼ 0.674). Japanese patients, however, experienced
a significant 100% higher non-CVD mortality risk on Fridays
versus the 7-day average (P¼ 0.001).
In Figure 5, HRs of CVD and non-CVD mortality by day
of the week for TTS schedule patients is displayed. In the
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Figure 2 |Relative risk of mortality (all-cause) by day. (a) US
patients receiving dialysis on Monday–Wednesday–Friday (MWF).
Covariate-adjusted hazard ratios (HRs) of all-cause mortality by
day of the week with MWF schedule for US patients. The reference
is the average of 7 days of the week. The asterisks (*) mean that
the effect is significant. (b) European patients receiving dialysis on
MWF. Covariate-adjusted HRs of all-cause mortality by day of the
week with MWF schedule for European patients. (c) Japanese
patients receiving dialysis on MWF. Covariate-adjusted HRs of
all-cause mortality by day of the week with MWF schedule for
Japanese patients.
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Figure 3 |Relative risk of mortality (all-cause) by day. (a) US
patients receiving dialysis on Tuesday–Thursday–Saturday (TTS).
Covariate-adjusted hazard ratios (HRs) of all-cause mortality by
day of the week with TTS schedule for US patients. The reference
is the average of 7 days of the week. The asterisks (*) mean that
the effect is significant. (b) European patients receiving dialysis on
TTS. Covariate-adjusted HRs of all-cause mortality by day of the
week with TTS schedule for European patients. (c) Japanese
patients receiving dialysis on TTS. Covariate-adjusted HRs of
all-cause mortality by day of the week with TTS schedule for
Japanese patients.
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United States, CVD mortality risk was higher by 56% on
Tuesdays relative to the 7-day average (Po0.0001); patients
also experienced a significant 26% higher non-CVD mortal-
ity risk on Tuesdays (P¼ 0.016). In Europe, patients
experienced a 43% higher risk of CVD mortality on Tuesdays
(P¼ 0.058), with the corresponding value for non-CVD
mortality being 15% (P¼ 0.236). However, European
patients had an 88% higher risk of CVD death on Saturdays
(P¼ 0.001). In Japan, patients experienced a significant 75%
higher risk of CVD mortality on Tuesdays (P¼ 0.037) and
also experienced a 93% higher CVD mortality risk on
Saturdays (P¼ 0.034). However, in Japan there was no
evidence of higher non-CVD mortality on Tuesdays com-
pared with the 7-day average (HR¼ 1.26; P¼ 0.300).
Cox models were fitted to all patients (that is, combining
the United States, Europe, and Japan) to study which patient
characteristics were associated with the day-of-week effect on
all-cause mortality. For this part of the analysis, we focused
specifically on the impact of sex, 14 comorbid conditions,
and vascular access type on each of the two effects: the
mortality elevation on Mondays (for MWF schedule patients)
and that on Tuesdays (for TTS patients). The results are listed
in Tables 2 and 3. None of the above-listed factors seemed to
modulate the effects, with the possible exceptions of cancer
2a
b
c
1.5
1 0.94 0.82*
1.55*
1.27*
1.17
0.78 0.87
1.05
0.87 0.83
1.33*
0.86
1.000.93
1.45*1.38*
0.94
1.08 1.06 1.02
0.71*
0.88
0.89
1.12
0.82
1.23
1.01 1.09
0.55
0.91
0.75 0.79
0.93
2.00*
0.84
1.62
1.10
0.91
1.05 1.05 1.00
0.87
0.5
R
R
 m
or
ta
lit
y
CV
D
N
on
-C
VD
CV
D
N
on
-C
VD
CV
D
N
on
-C
VD
R
R
 m
or
ta
lit
y
0
2
1.5
1
0.5
0
R
R
 m
or
ta
lit
y
2
2.5
1.5
1
0.5
0
Sun Mon Tue Wed Thu Fri Sat
Sun Mon Tue Wed Thu Fri Sat
Sun Mon Tue Wed Thu Fri Sat
Figure 4 |Relative risk of mortality (cardiovascular disease
(CVD) and non-CVD) by day. (a) US patients receiving dialysis on
Monday–Wednesday–Friday (MWF). Covariate-adjusted hazard
ratios (HRs) of CVD and non-CVD mortality by day of the week
with MWF schedule for US patients. The reference is the average
of 7 days of the week. The asterisks (*) mean that the effect is
significant. (b) European patients receiving dialysis on MWF.
Covariate-adjusted HRs of CVD and non-CVD mortality by day of
week with MWF schedule for European patients. (c) Japanese
patients receiving dialysis on MWF. Covariate-adjusted HRs of CVD
and non-CVD mortality by day of the week with MWF schedule for
Japanese patients.
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Figure 5 |Relative risk of mortality (cardiovascular disease
(CVD) and non-CVD) by day. (a) US patients receiving dialysis on
Tuesday–Thursday–Saturday (TTS). Hazard ratios (HRs) of CVD and
non-CVD mortality by day of the week with TTS schedule for US
patients. The reference is the average of 7 days of the week. The
asterisks (*) mean that the effect is significant. (b) European
patients receiving dialysis on TTS. HRs of CVD and non-CVD
mortality by day of week with TTS schedule for European patients.
(c) Japanese patients receiving dialysis on TTS. HRs of CVD and
non-CVD mortality by day of the week with TTS schedule for
Japanese patients.
Table 2 | RR of death (all-cause) by sex (United States, Europe,
and Japan)
Comparison Schedule RR, male RR, female P-value (difference)
Monday vs. Avg MWF 1.32 1.47 0.152
Tuesday vs. Avg TTS 1.45 1.20 0.028
Abbreviations: Avg, average; MWF, Monday–Wednesday–Friday; RR, relative risk;
TTS, Tuesday–Thursday–Saturday.
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(other than skin) being associated with a lower risk of all-cause
mortality on Mondays (for MWF schedule patients) and on
Tuesdays (for TTS patients; HR¼ 1.18 for patients with cancer
(other than skin), HR¼ 1.40 for patients without cancer
(other than skin), P-value¼ 0.033); neurological disease being
associated with a higher risk of all-cause mortality on
Mondays (MWF schedule) and on Tuesdays (TTS schedule;
HR¼ 1.59 for patients with neurological disease, HR¼ 1.33
for patients without neurological disease, P-value¼ 0.041);
and sex, where the effect on Tuesday was higher for men on a
TTS schedule.
A final Cox model was fitted, which combined DOPPS-I
patients from the United States, Europe, and Japan, to
determine whether time-dependent measures of blood
pressure, potassium, sodium, ultrafiltration rate, intradialytic
weight loss, residual renal function (RRF), and the use of
diuretics modify the Monday and Tuesday effects. Table 4
shows that low ultrafiltration rate was associated with higher
risk of all-cause mortality on Mondays with MWF schedule
and on Tuesdays with TTS schedule. Diuretic use was
associated with lower risk of all-cause mortality on Mondays
with MWF schedule and on Tuesdays with TTS schedules.
DISCUSSION
Despite its proven value as a life-saving therapy, HD remains
an intermittent intervention, most typically administered
three times a week. Harmful waste products and fluid
accumulated over the extended weekend interval may
therefore put patients at a higher risk of death on certain
days. Our results from the DOPPS in the US, European, and
Japanese patients indicate that, in all three regions, HD
patients have a higher risk of all-cause death on Mondays if
they are on a MWF schedule, or Tuesdays if they are on a TTS
schedule. Thus, findings from prior reports1,3 are corrobo-
rated and expanded upon here. This day-of-week effect tends
to be stronger for CVD than non-CVD death overall.
The European and Japanese data tend to confirm the
effect, quite evident in the US data, of increased mortality on
the day of the first dialysis session in the week. On the other
hand, there are unique features to the results in Europe and
Japan, such as high mortality on Saturdays in the TTS
schedule, which may be due to practice patterns unique to
those countries/regions. Such practice patterns could, for
example, include continued aggressive/usual ultrafiltration
and dialysis on Fridays or Saturdays (the last dialysis session
of the week) in order to allow for the anticipated longer
weekend gap in dialysis, despite the patients being closer to
their target postdialysis weight at the time of the last dialysis
session of the week. This could predispose to a greater degree
of intradialytic hypotension and/or hypokalemia, which in
turn would increase the tendency for CVD events, including
sudden death. However, this mechanism, although plausible,
remains speculative.
Nondialysis days had lower relative risks for mortality
compared with dialysis days, perhaps because dialysis itself
increases the risk of mortality. For HD patients, very large
amounts of fluids and toxins are removed in a relatively short
time period, particularly if the time elapsed since the last
dialysis is long. This increases the potential for occurrence of
intradialytic hypotension, which has previously been found
to be a risk factor for mortality among HD patients.4,5 Rapid
reduction in postdialysis potassium may also be a con-
tributory factor, as hypokalemia can enhance the risk for
cardiac arrhythmia and sudden death, and this is more likely
to occur on a dialysis day as opposed to the day preceding
dialysis.
This study presents some evidence that the day-of-week
effect is modulated by cancer (other than skin), neurological
disease, sex, low ultrafiltration rate, and use of diuretics, but,
apparently, not by other suspected factors including other
comorbid conditions, blood pressure, serum potassium,
serum sodium, intradialytic weight loss, and RRF (the hazard
ratio for the interaction with day of the week in this instance
was protective but statistically nonsignificant). Potential
explanations toward the interpretation of some of these
interactions are again speculative. For those with cancer, it
could be speculated that the interaction with first day of the
week was associated with lower mortality because the
mechanism of death may predominantly be through non-
cardiovascular mechanisms. Those with neurological disease
may have an accentuated early-in-the-week effect because of
vascular diseases being the underlying cause for many types
of neurological diseases (for example, cerebrovascular
disease). Similarly, males have a greater association with
Table 3 |Modification of Monday and Tuesday effect by comorbid conditions and by using catheter as vascular access (United
States, Europe, and Japan)
Comorbid conditions Interaction with Monday and Tuesday Comorbid conditions Interaction with Monday and Tuesday
Cerebrovascular disease 1.03 (0.699) HIV 0.79 (0.383)
Congestive heart failure 0.99 (0.891) Hypertension 1.09 (0.210)
Coronary heart disease 1.05 (0.380) Lung disease 1.00 (0.956)
Other cardiovascular diseases 1.02 (0.696) Neurological disease 1.20 (0.039)
Cancer (other than skin) 0.84 (0.034) Peripheral vascular disease 1.05 (0.400)
Diabetes 1.01 (0.924) Psychiatric disorder 0.92 (0.166)
Gastrointestinal bleeding 1.01 (0.955) Recurring cellulitis, gangrene 1.01 (0.899)
Catheter use Interaction with Monday and Tuesday
Catheter 0.98 (0.760)
Numbers in the parentheses are the corresponding P-values.
A value of o1 (41) means the factor was associated with a decreased (increased) risk of all-cause mortality on Mondays with Monday–Wednesday–Friday (MWF) schedule
and on Tuesdays with Tuesday–Thursday–Saturday (TTS) schedule.
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CVD and hence may have an interaction with early-in-the-
week mortality. Low ultrafiltration rate may at least in part
reflect patients especially prone to dialysis-related hypoten-
sion, which is itself a predictor of worse patient outcomes,
particularly the finding that modification of the early-in-the-
week mortality risk in association with diuretic use has
therapeutic implications, especially in patients with signifi-
cant RRF who are likely to be responsive to diuretic therapy.
This is consistent with previously published DOPPS findings
showing a lower mortality among those receiving diuretics.6
Low ultrafiltration may represent patients with low blood
pressure to begin with, or those who are malnourished, thus
being associated with higher early-in-the-week mortality.
Clearly, associations found in these exploratory analyses
require confirmation in future studies.
Some limitations of our study are as follows. Dialysis
schedule was inferred from the date of reporting of dose
of dialysis, which was collected once every 4 months. It was
not possible to obtain the schedule information directly.
In addition, the DOPPS data do not include the exact time of
death or the timing of dialysis sessions, both of which would
be useful additional data in further understanding the day-
of-week effect. The secondary end point of CVD death is
certainly of interest, but CVD death may not be ascertained
completely or determined consistently across centers. Such
limitations are typical of studies using large observational
databases. Because of both the smaller sample size and lower
event rate, inferences pertaining to Japanese HD patients are
subject to substantially more uncertainty than those for US
patients. Countries within Europe also have smaller sample
sizes. However, these countries share similar genetic and
environmental factors, as well as practice patterns, at least to
some extent. In the analyses reported here, Europeans were
considered as a single group, and conclusions were made
about average effects over the 5–7 countries from this entire
region. Larger samples from each country could examine
differences within Europe. DOPPS-II also includes data from
Canada, Australia, and New Zealand, but the sample sizes in
these countries were too small to support reliable conclusions
in this study. Noncompliance has been observed to be most
common in the United States and least common in Japan.
Non-adherence with dialysis sessions (‘shortening’ or ‘skip-
ping’ sessions) has been associated with higher mortality as
detailed in a previous DOPPS paper,7 and would be expected
to raise overall mortality rates. Unfortunately, there is
insufficient information to assess the rate or effect of
noncompliance in the DOPPS data. Finally, a substantial
proportion (66%) of patients died in the hospital. Often,
patients who are hospitalized would no longer follow their
regular dialysis schedule. In this case, one would expect the
observed day-of-week effect in this study to be somewhat
attenuated. Further study that considered the potential
confounding effect of hospitalization would be valuable.
Our results imply that there may be an advantage to a more
frequent dialysis schedule in Europe, the United States, and
potentially Japan. This is supported by the relatively low rates
of mortality for patients receiving ‘daily dialysis’ based on
various reports.8–11 One could hypothesize that more frequent
dialysis would reduce or eliminate the day-of-week effect and,
therefore, lower mortality on HD. Many previous reports have
found that daily dialysis is beneficial. For example, Woods
et al.8 found that for certain patients daily HD might have
advantages over three times a week HD. Blagg et al.9 observed
that patients treated by short daily HD had a better survival
rate than those treated by conventional HD. Kjellstrand et al.10
reported that the survival of United States Renal Data System
patients on short daily HD was 2–3 times lower than that of
matched three times a week HD patients. Johansen et al.11
examined survival and hospitalization between frequent HD
patients and patients undergoing three times a week conven-
tional HD. Their study found that there was a nonsignificant
reduction in death risk for patients using short daily HD,
whereas hospitalization patterns did not differ significantly
between daily HD patients and their matched counterparts.
There are many reasons why daily HD may improve patient
survival. Daily HD can minimize fluid volumes,10 and improve
many abnormal physiological parameters and metabolic
markers associated with a high mortality.12–16 Quality of life
has been reported to improve for patients on daily HD.17,18
However, the term ‘daily’ has been defined differently in these
studies. It can mean 5–6, 5–7, or 4–7 times of dialysis per week.
Hence, there is the possibility that death rates are still elevated
on the first and/or last day of dialysis. Therefore, our results do
not imply directly that a more frequent dialysis could reduce
mortality. We would need to analyze the data using a cohort
that received daily dialysis in order to determine whether day-
of-week effect really disappeared and, hence, whether mortality
was reduced.
Table 4 |Modification of Monday and Tuesday effect by time-dependent factors (DOPPS-I: United States, Europe, and Japan)
Time-dependent covariate Interaction with Monday and Tuesday Time-dependent covariate Interaction with Monday and Tuesday
Blood pressure low 0.84 (0.054) Blood pressure high 1.19 (0.140)
Potassium low 0.85 (0.142) Potassium high 1.15 (0.275)
Sodium low 1.08 (0.496) Sodium high 1.06 (0.662)
Ultrafiltration rate low 1.28 (0.019) Ultrafiltration rate high 0.94 (0.570)
Weight loss low 1.11 (0.292) Weight loss high 1.07 (0.609)
RRF 0.80 (0.096) Diuretic use 0.62 (0.003)
Abbreviations: DOPPS-I, Dialysis Outcomes and Practice Patterns Study, phase I; RRF, residual renal function.
Numbers in the parentheses are the corresponding P-values.
A value of o1 (41) means the factor was associated with a decreased (increased) risk of all-cause mortality on Mondays with Monday–Wednesday–Friday (MWF) schedule
and on Tuesdays with Tuesday–Thursday–Saturday (TTS) schedule.
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Bliwise et al.19 investigated the association of HD treatment
shift with continued survival among elderly patients. Their
study found that the morning-shift HD patients survived
significantly longer than the afternoon-shift patients. In the
present study, we observed a higher risk of all-cause mortality
among European patients on Saturdays on a TTS schedule and
a higher risk of CVD mortality among European and Japanese
patients on Saturdays on a TTS schedule.
In summary, we have carried out a comprehensive analysis
of the interaction between dialysis schedule and day-of-the-
week-specific mortality among HD patients in the United
States, Europe, and Japan. Limitations associated with the
DOPPS database suggest future directions for research in this
area. In particular, future studies aimed at evaluating the
benefit of additional weekly dialysis sessions or alternate-day
dialysis should also assess the impact of schedule on day-of-
week-specific mortality. Utilization of diuretics among those
with significant RRF is another potential area fertile for
further study, in addition to examination of other practice
patterns that can reduce early-in-the-week mortality for
those on conventional three times a week HD schedule, as
this is likely to remain the norm for the vast majority of HD
patients, at least for the foreseeable future. Further study of
data with the exact time of death and the timing of dialysis
sessions would be valuable in further understanding the day-
of-week effect.
MATERIALS AND METHODS
Data were obtained on the US, Japanese, and European (Belgium,
France, Germany, Italy, Spain, Sweden, and United Kingdom)
patients from the DOPPS phases I and II. The overall design of the
DOPPS has been described in some detail previously.20,21 In total,
the study population consisted of 22,163 patients: 9227 were from
the United States, 8517 from Europe, and 4419 from Japan. For each
patient, follow-up began at entry into the DOPPS. Patients were
then observed until the earliest of death, transplant, loss to follow-
up, or the end of the observation period: 31 December 2001 for
phase I patients, and 31 December 2004 for Phase II patients. The
mean follow-up time is 569 days for phase I patients and 564 days
for phase II patients. Approximately 5% of patients received a
transplant, and 4% of patients withdrew from the study. The
primary outcome of interest is death (all-cause, CVD, and non-
CVD). The date and cause of death were recorded. CVD mortality
was defined as death with primary cause being any of the following:
acute myocardial infarction, hyperkalemia, pericarditis, athero-
sclerotic heart disease, cardiomyopathy, cardiac arrhythmia, cardiac
arrest, valvular heart disease, pulmonary edema due to exogenous
fluid, or congestive heart failure.
Baseline data on demographics, laboratory values, medical
history, and medications were collected at the start of participation
in the DOPPS. Thereafter, longitudinal data were collected at 4-
month intervals, including updated hospitalization events, vascular
access, laboratory values, medications, dialysis prescription, dialysis
dose, and RRF. Detailed information is also reported for the final
dialysis session in the 4-month period, including the date when
dialysis was received. For purposes of analysis, if the reported date
was a Monday, Wednesday, or Friday, the dialysis schedule was
considered to be MWF in the corresponding 4-month interval. The
TTS dialysis schedule was defined in a similar manner. If this date
was missing or was a Sunday, the dialysis schedule was carried over
from the preceding 4-month reporting interval. Approximately 79%
of patients did not switch the dialysis schedule in this study, 13%
patients switched once, either from MWF to TTS or from TTS to
MWF, and 8% patients switched more than once.
Baseline characteristics for prevalent patients (at the start of
DOPPS I and II, n¼ 13,820) were summarized, with simple means
for continuous variables and proportions for categorical variables.
The covariate of interest is the day of the week (Sunday, Monday,
y, Saturday), which was coded as a time-dependent covariate in a
Cox model, with time of origin as the first ever HD day. As patients
were not under observation until they entered the DOPPS study,
using timescale of days since study entry can be subject to left-
truncation bias; therefore, we used days since onset of dialysis
(dialysis vintage) as the timescale. Adjustment covariates included
sex, race, 14 comorbid conditions (coronary heart disease, cancer
other than skin, other CVD, cerebrovascular disease, congestive
heart failure, diabetes, gastrointestinal bleeding, HIV/AIDS, hyper-
tension, lung disease, neurological disease, psychiatric disorder,
peripheral vascular disease, and recurrent cellulitis), body mass
index (grouped as o20, 20–25, 25–30, and X30 kg/m2), and
vascular access (catheter use). Dialysis schedule, country, phase, and
age group (18–29, 30–39, 40–44, 45–49, 50–54, 55–59, 60–64, 65–69,
and X70 years) were adjusted through stratification. As patients
from the same facility may be correlated because of shared practice
patterns, valid statistical procedures must account for intracluster
dependence, which was done using a robust (‘sandwich’) estimator
of the covariance.22
Cox models were fitted to each region (United States, Europe,
and Japan) separately. In all models, day of the week was coded such
that each day was compared with the average of the 7 days of the
week. Table 5 shows the coding of the time-dependent covariates
related to day of the week. The average of the 7 days of the week is
constrained to be zero in the model; therefore, each day was
compared with this geometric average (that is, zero). The
comparison of each level of a categorical predictor with the average
is as defensible statistically as the comparison of each level with a
reference level. The former is used much less frequently than the
latter, but is the best choice for our analysis.
Further analyses used Cox models fitted to patients from all three
regions combined, in order to study whether sex, 14 comorbid
conditions, and vascular access (catheter use) modified the day-of-
week effect. Models including interactions between region and day
of the week have been compared with those without such
interactions. As only small differences in estimates are observed
between these two models, only results from the latter models are
reported in this article. Moreover, in assessing the potential
modifiers of the day-of-week effect, we found that the interactions
between the modifiers and Mondays (for MWF schedule patients)
are similar to those between the modifiers and Tuesdays (for TTS
Table 5 | Coding for time-dependent covariates
Time-dependent covariate Sun Mon Tue Wed Thu Fri Sat
Z1 1 1 0 0 0 0 0
Z2 1 0 1 0 0 0 0
Z3 1 0 0 1 0 0 0
Z4 1 0 0 0 1 0 0
Z5 1 0 0 0 0 1 0
Z6 1 0 0 0 0 0 1
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schedule patients); thus, in the models reported, these interactions
are assumed to be equal and combined. Furthermore, another Cox
model was fitted to the laboratory covariates of all patients (blood
pressure, potassium, sodium, ultrafiltration rate, weight loss, RRF,
and the use of diuretics). Each of these variables, except RRF and
diuretic use, was categorized into three groups: low (lowest
quartile), normal (middle two quartiles), and high (highest
quartile). These time-dependent covariates were measured monthly
in the unit, and weight loss was measured with each treatment.
However, the DOPPS updated such measures only every 4 months.
In this last time-dependent analysis, results were based on DOPPS-I
data because only baseline potassium and sodium values were
available in DOPPS-II.
In this study, the covariate of interest is day of the week (Sunday,
Monday, y, Saturday). We defined time-dependent covariates
based on the day of the week. Cox regression analyses used the
PHREG procedure (SAS Institute, Cary, NC), and handled time-
dependent covariates and left truncation through the counting
process style of input. Facility clustering effects were accounted for
through the robust sandwich covariance estimates. In the SAS
PHREG procedure, this is implemented using the COVS(AGGRE-
GATE) option, with ID specified as facility (SAS 9.2 documentation,
example 64.11 in the PHREG procedure23). As implied, all statistical
analyses were conducted using SAS V9.2 (SAS Institute).
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